Professor Sagar Lonial

Co-Chair

Winship Cancer Institute at Emory University, Atlanta, US

Dr Sagar Lonial, MD, is a world leader in Multiple Myeloma (MM) treatment and research. He currently holds the position of Professor and Chair in the Department of Hematology and Medical Oncology, as well as Chief Medical Officer, at the Winship Cancer Institute of Emory University.

His research focusses on immunotherapy in MM and he recently established the B cell malignancy program in order to test novel agents in the laboratory, and drive them into early clinical trials. Previous lines of research included the interplay with cytokines and dendritic cells, as well as post-transplant immune recovery. Alongside his research, he works as a lead member of the bone marrow transplant team.

Dr Lonial studied Medicine at the University of Louisville School and undertook his residency at Baylor College of Medicine in Houston, Texas. He then spent a year as a Chief Medical Resident at the Ben Taub General Hospital, and a year at the Texas Heart Institute and St. Lukes Hospital, before taking up a fellowship at the Emory University School of Medicine in Atlanta, Georgia, where he completed his hematology and oncology training.

Dr Lonial is a member of several professional organizations, including the American Society of Clinical Oncology, American Society of Hematology, and the American Society for Blood and Marrow Transplantation. He holds the position of Vice Chair of the Myeloma Committee in the Eastern Cooperative Oncology Group (ECOG) and is also Chair of the Steering Committee for the Multiple Myeloma Research Consortium. He is also a member of the scientific Advisory Board for the International Myeloma Foundation (IMF), and is secretary for the International Myeloma Society (IMS). He currently works with the Discovery and Developmental Therapeutics Research Program of the Winship Cancer Institute of Emory University. He serves on the editorial board of the Journal of Clinical OncologyLeukemia, is the myeloma editor for Clinical Lymphoma, Myeloma, and Leukemia, and is the hematologic malignancies section editor for the journal Cancer. Dr Lonial has been awarded a number of accolades including the Houston Society of Internal Medicine, Best Resident in Internal Medicine in 1995, the Henry B. Macintosh Award in 1996, Celgene 'Young Investigator' Award and 'Top 15 Innovator' Award. In April 2017 he took up the position of co-chair of the Multiple Myeloma Hub.